As of 3:49pm ET
| +0.0311 / +4.32%|
The 1 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 1.59, with a high estimate of 1.59 and a low estimate of 1.59. The median estimate represents a +111.76% increase from the last price of 0.75.
The current consensus among 1 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.